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ABSTRACT 
Antimicrobial photodynamic therapy (aPDT) kills several planktonic pathogens. 
However, the susceptibility of biofilm-derived anaerobic bacteria to aPDT is poorly 
characterized. Here, we evaluated the effect of Photodithazine (PDZ)-mediated aPDT on 
Fusobacterium nucleatum and Porphyromonas gingivalis biofilms. In addition, aPDT 
was tested with metronidazole (MTZ) to explore the potential antimicrobial effect of the 
treatment. The minimum inhibitory concentration (MIC) of MTZ was defined for each 
bacterial species. Single-species biofilms of each species were grown on polystyrene 
plates under anaerobic conditions for five days. aPDT was performed by applying PDZ at 
concentrations of 50, 75 and 100 mg/L, followed by exposure to 50 J/cm
2
 LED light (660 
nm) with or without MTZ. aPDT exhibited a significant reduction in bacterial viability at 
a PDZ concentration of 100 mg/L, with 1.12 log10 and 2.66 log10 reductions for F. 
nucleatum and P. gingivalis in biofilms, respectively. However, the antimicrobial effect 
against F. nucleatum was achieved only when aPDT was combined with MTZ at 100x 
MIC. Regarding P. gingivalis, the combination of PDZ-mediated aPDT at 100 mg/L with 
MTZ 100x MIC resulted in a 5 log10 reduction in the bacterial population. The potential 
antimicrobial effects of aPDT in combination with MTZ for both single pathogenic 
biofilms were confirmed by live/dead staining. These results suggest that localized 
antibiotic administration may be an adjuvant to aPDT to control F. nucleatum and P. 
gingivalis biofilms.  
Keywords: photodynamic therapy, combined modality therapy, metronidazole, anaerobic 
bacteria 
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1. Introduction 
The ability of microbial cells to interact with abiotic and biotic surfaces [2-4] enables the 
formation of a complex microbial community surrounded by an extracellular matrix of 
polymeric substances [5, 6]. This organized structure, a biofilm, promotes an imbalance 
between microorganisms of the normal flora and opportunistic pathogens and is 
considered the precursor to the initiation of the inflammatory response by the host [7, 8]. 
Among bacteria involved in this process, Gram-negative species have virulence factors 
directly related to several aggressive oral infections, such as periodontal and peri-implant 
diseases [9, 10].  
The microbiota in periodontal and peri-implant pockets include both P. gingivalis 
and F. nucleatum [11-14]. P. gingivalis is a significant pathogenic species directly related 
to the progression of both diseases [15] because of the numerous toxic enzymes produced 
by most of its strains [16] and its communication with host cells that triggers a strong 
inflammatory response [17, 18]. F. nucleatum is another critical organism strongly 
associated with periodontal and peri-implant diseases due to congregation with other 
species (including P. gingivalis) via its high number of multivalent adhesins onto cell 
surfaces [19-22]. In addition, this bacterium can generate a capnophilic environment that 
enables the growth of anaerobic pathogenic bacteria, including P. gingivalis [23-29]. 
Finally, the interaction between F. nucleatum and host cells enhances the invasion of P. 
gingivalis into host cells [30]. Considering bacterial aggressiveness and possible sequelae 
provoked by disease progression (tooth/implant loss), biofilm control on oral substrates is 
critical for controlling the inflammatory response. 
From a clinical point of view, nonsurgical treatment directed toward mechanical 
removal of subgingival biofilms is mainly limited by the depth of periodontal/peri-
implant pockets and surface irregularities [31]. In consideration of the limited effects of 
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mechanical debridement [32], the further benefits of antibiotic therapy must be weighed 
against concerns regarding increases in antibiotic resistance [33]. The antibiotic resistance 
crisis, attributed to the systemic overuse and misuse of these medications, has pressured 
researchers to investigate new strategies to avoid dental or implant damage as a 
consequence of infection progression [33-35]. Thus, antimicrobial photodynamic therapy 
(aPDT) has been introduced as a potential alternative approach for the bacterial 
decontamination of tooth or implants surfaces [36, 37]. 
The success of aPDT requires that a photosensitizer (PS) be adsorbed by microbial 
cells and become adsorbed by the cell wall with subsequent activation by light irradiation. 
As the desired mechanism of action, singlet oxygen and free radicals produced by the 
irradiated PS will interact with cell structures, thereby damaging the cytoplasmic 
membrane and DNA, which leads to cell death [38, 39]. Among the commercially 
available PSs, Photodithazine (PDZ), which is based on chlorine e6 (Ce6), is a second-
generation PS with potential antimicrobial effects against pathogenic microorganisms and 
low toxicity at appropriate concentrations [40]. Our previous in vitro [41, 42] and in vivo 
[40, 43] outcomes have demonstrated the successful inactivation of fungal Candida spp. 
biofilms by aPDT with PDZ. However, information on the effects of PDZ-mediated 
aPDT on anaerobic bacteria species is lacking.  
Therefore, here, we evaluated the effects of PDZ-mediated aPDT on F. nucleatum 
and P. gingivalis biofilms. Furthermore, we investigated the association of this approach 
with an antibiotic commonly prescribed for periodontal and peri-implant diseases.  
 
2. Materials and Methods 
2.1 Human saliva preparation 
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Human saliva collection was carried out after approval by the Institutional Ethical 
Committee (CAAE 26142014.0.0000.5416). Unstimulated saliva was obtained from three 
healthy male adults aged between 25 and 30 years. The inclusion criteria were as follows: 
no active caries or periodontal disease, no systemic disease and no antibiotic-related 
therapy for at least three months before the study. After collection, saliva was mixed and 
clarified by centrifugation at 10,000 g for 15 minutes at 4°C [44]. Immediately after 
centrifugation, the clarified saliva was filtered with a Millipore
®
 (Merck Millipore Group, 
MA, USA) membrane 0.22-μm pore size filter and stored at -80°C until use [45, 46].  
 
2.2 Bacterial strains and inoculum preparation  
F. nucleatum (National Collection of Type Cultures (NCTC) 11326) and P. gingivalis 
(American Type Culture Collection (ATCC) 32277) were grown on Brucella agar 
(HiMedia) with 5% defibrinated sheep blood (Microlab) at 37°C under anaerobic 
conditions (85% N2, 10% de H2, and 5% CO2) (Don Whitley Scientific, England). After 
48 hours, bacterial colonies were transferred to 10 mL Brain Heart Infusion (BHI–Difco 
Laboratories Inc, MI, USA) broth medium supplemented with hemin (10 mg/mL), 
menadione (5 mg/mL) and yeast extract (6 g/L), followed by incubation at 37°C and 
anaerobiosis for 24 hours. Subsequently, 500 µL bacterial cells was suspended in 9.5 mL 
fresh BHI broth medium and incubated under anaerobic conditions until reaching the 
midexponential phase, according to the following established growth curves: 15 hours for 
P. gingivalis and 5 hours for F. nucleatum [47]. Finally, the bacterial cell concentrations 
were set at 10
7
 colony-forming units (CFU)/mL for each species with a 
spectrophotometer (Spectrum–SP 2000 UV) at a wavelength of 600 nm.  
 
2.3 Antibacterial susceptibility testing 
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Planktonic susceptibility tests were performed following the Clinical and Laboratory 
Standards Institute guidelines (M07-A9, 2012) [48]. Briefly, 95 μL metronidazole (MTZ–
Sigma-Aldrich, St. Louis, MO, USA) was serially diluted from 32 to 0.015 µg/mL in BHI 
broth medium in a 96-well plate. Then, five μL of each bacterial species was added at 
1×10
7
 CFU/mL into each well, bringing the final volume to 100 μL after the inoculation. 
Bacteria were also inoculated directly into polystyrene plates to serve as growth controls, 
while medium without bacterial inoculation served as a negative control for growth. 
Plates were incubated under anaerobic conditions at 37°C for 24 hours. Next, the bacterial 
growth in the plate was measured at 595 nm with a spectrophotometer (Spectrum–SP 
2000 UV, Mettler-Toledo Ind. and Com. Ltda, SP, Brazil). The minimum inhibitory 
concentration [1] was considered the lowest antibiotic concentration capable of inhibiting 
at least 100% of bacterial growth compared to the growth controls and media without 
bacterial inoculation. 
 
2.4 Biofilm formation  
The single-species biofilms of F. nucleatum and P. gingivalis were formed as previously 
described [47]. Briefly, a conditioned saliva-derived film (i.e., salivary pellicle) was 
developed for the attachment of the initial pathogenic biofilm. Fifty μL sterilized saliva 
was added to each well of a 96-well plate (Corning Costar cell culture plates; Fisher 
Scientific, NY, USA) and kept in an orbital shaker (75 rpm) at 37°C [49]. After 4 hours 
of incubation, the saliva was removed, and the wells were gently washed twice with 100 
μL sterile phosphate-buffered saline (PBS). A 150 µL aliquot of each bacterial species at 
1x10
7 
cells/mL was individually inoculated onto the acquired salivary pellicle, and the 
plates were incubated at 37°C under anaerobic conditions. Following 24 hours of the 
adhesion phase, unbound cells were removed by gentle washing with 200 µL PBS, and 
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150 µL fresh BHI-supplemented broth medium was added to promote biofilm formation. 
Plates were statically incubated at 37°C under anaerobic conditions for five days, and the 
culture medium was replaced every 24 hours. Bacterial species individually cultured in 
the polystyrene plate served as a positive control for biofilm formation. For all 
experiments, the wells were washed twice with 200 μL PBS at the end of the incubation 
period before further analyses. 
 
2.5 PDZ-mediated aPDT: photosensitizer and light source properties  
Stock solutions of PDZ (VETA-GRAND Company, Moscow, Russia) diluted in saline 
solution were freshly prepared at concentrations of 50, 75 and 100 mg/L and stored in the 
dark at room temperature until use. Red light-emitting diode (LED) light irradiation was 
used with a constant dose of 50 J/cm
2
 at a 660 nm excitation wavelength with a power 
density of 71.7 mW/cm² for 28 minutes.  
 
2.6 Effect of PDZ-mediated aPDT on biofilms 
 To understand the effect of PDZ on bacterial cell viability, we incubated single-species 
biofilms of F. nucleatum and P. gingivalis with PDZ at the following concentrations: 50 
mg/L, 75 mg/L and 100 mg/L. PDZ activity without light irradiation was compared to 
PDZ-mediated aPDT activity.  
After an incubation period for the formation of biofilms, wells were washed twice 
with PBS, and 200 μL aliquots of PDZ were added to the experimental samples, aPDT 
and PDZ. For controls, biofilms were incubated with 200 μL PBS with and without light 
irradiation (L
+
 and L
-
, respectively). All samples were incubated at room temperature for 
10 minutes in darkness, as a preirradiation phase. In sequence, a 96-well plate containing 
PBS and PDZ groups was submitted to LED irradiation for 28 minutes and defined as 
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follows: aPDT 50 mg/L, aPDT 75 mg/L and aPDT 100 mg/L. Concomitantly, another 96-
well plate containing PBS and PDZ was kept in the dark with the groups PDZ 50 mg/L, 
PDZ 75 mg/L and PDZ 100 mg/L. After treatments, 200 μL PBS was added to all of the 
wells, and bacterial cells were harvested from the polystyrene wells by scraping with a 
sterile pipette tip. In sequence, bacterial culture was re-suspended several times using a 
pipette tip and a vortex to disperse the cells before serial dilution procedure. Then, 25 μL 
of ten-fold, serially diluted samples was plated on Brucella agar. The plates were 
incubated at 37°C under anaerobic conditions for seven days. Colony counts were then 
obtained with a digital colony counter and expressed as CFU/mL. The experiments were 
conducted in triplicate on three distinct experimental occasions.  
 
2.7 Effect of PDZ-mediated aPDT on biofilms in comparison with MTZ 
The effect of aPDT on biofilms was compared with that of MTZ. For each experiment, 
biofilm samples were formed in two different 96-well plates, corresponding to the 
irradiated and nonirradiated groups. For the PDZ-mediated aPDT groups, the procedures 
were performed as previously described (see 2.6). For the antibiotic-treated groups, 5-
day-old biofilm samples were washed twice with PBS and then incubated with 200 μL 
MTZ at the following concentrations: MIC (MTZ MIC), MIC 50x (MTZ 50x) and MIC 
100x (MTZ 100x) for 24 hours. Next, 25 μL of PBS serially diluted samples was plated 
on Brucella agar, and the plates were incubated at 37°C to obtain CFU/mL values after 7 
days. The experiments were performed in triplicate and on three different occasions.    
 
2.8 Potential effect of combination therapy on biofilms 
Another approach to overcome F. nucleatum and P. gingivalis biofilms was to combine 
aPDT with local antibiotic administration. Here, 5-day-old biofilm samples were 
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subjected to aPDT 50 mg/L, aPDT 75 mg/L and aPDT 100 mg/L and in sequence, 
incubated with 200 µL MTZ at the following concentrations: MTZ MIC, MTZ 50x and 
MTZ 100x, for 24 hours. At the end of the incubation period, biofilms were harvested in 
PBS, and 25 μL serially diluted cultures was plated on Brucella agar to obtain viable 
colonies after seven days. All experiments were performed in triplicate with three 
repetitions to ensure biological reproducibility.  
For each experiment, biofilm samples were assessed in two different plates 
corresponding to red LED light exposure (aPDT) and a dark room. Additionally, biofilm 
samples submitted to PDZ-mediated aPDT or treated with MTZ, as well as bacterial cell 
concentrations inoculated on polystyrene, served as controls. 
 
2.9 Effect of PDZ-mediated aPDT/MTZ on biofilms under confocal analyses 
Biofilms were grown and treated as described in sections 2.4 and 2.5. The biofilm 
thickness and bacterial cell viability were evaluated via fluorescent labeling with a 
LIVE/DEAD BacLightTM Bacterial Viability staining kit (Invitrogen, Carlsbad, CA, 
USA) according to the manufacturer’s instructions. PBS-washed biofilm samples were 
visualized with a PASCAL LSM5 confocal laser-scanning microscope (Zeiss, Jena, 
Germany). Images were taken through 20x dry (Plan NeoFluar NA 0.3 air) objectives. 
Excitation wavelengths of 488 nm (Ar laser) and 561 nm (HeNe laser) were employed to 
reveal the effect of L
+
, aPDT 100 mg/L, MTZ 100x, L
+ 
MTZ 100x and aPDT 100 mg/L 
MTZ 100x on the distribution of live and dead bacterial cells, as well as their 
accumulated biomass.  
 
2.10 Statistical analyses 
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A schematic was designed to better represent the groups and methods used to conduct the 
investigation (Fig. 1). All experiments were performed in triplicate and repeated three 
times for each bacterial species (n  =  9) except for confocal analyses, which were 
performed in duplicate and repeated twice to ensure the reproducibility of the experiment. 
The data normality distribution was assessed using the D’Agostino-Pearson omnibus test. 
Normally distributed data were analyzed using one-way analysis of variance (ANOVA) 
with Tukey's post hoc test (p < 0.05). Nonnormally distributed data were analyzed using 
the Kruskal-Wallis test, followed by Dunn's multiple comparison test. The data presented 
are plotted as the mean ± standard deviation (SD) in a normal distribution. Nonnormally 
distributed data are plotted as the median ± SD. Analyses were performed using 
GraphPad Prism version 5.0c; p < 0.05 was considered statistically significant.  
 
3. Results 
3.1 Minimum inhibitory concentration  
MIC was considered the lowest concentration of MTZ that completely inhibited 100% of 
bacterial growth after 24 hours. The concentration was confirmed by cells plated on 
Brucella agar. The MIC values of MTZ were 1.0 μg/mL for F. nucleatum and 0.125 
μg/mL for P. gingivalis. 
  
3.2 PDZ-mediated aPDT on biofilms  
The number of viable colonies from single-species biofilms after PDZ incubation was 
compared to that after PDZ followed by light application (aPDT) to confirm the effect of 
the PS on bacterial cell reduction. Based on the data, for F. nucleatum, combining PDZ at 
the highest concentrations (75 and 100 mg/L) with red LED light irradiation is crucial to 
reduce the number of bacterial cells (Fig. 2A). However, different outcomes were 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
11 
 
 
observed for P. gingivalis biofilms since red LED light affected cell viability (L
-
) even in 
the absence of PDZ. Moreover, the CFU/mL reduction was higher when 100 mg/L PDZ 
was combined with red LED light (aPDT 100 mg/L) (Fig. 2B).  
 
3.3 PDZ-mediated aPDT compared to antibiotics (MTZ) applied to biofilms  
The following experiments were performed to compare the effect of MTZ alone on 
biofilm growth reduction with that of PDZ-mediated aPDT. F. nucleatum biofilm samples 
submitted to aPDT with 75 (aPDT 75 mg/L) and 100 mg/L (aPDT 100 mg/L) PDZ 
revealed significant reductions in CFU/mL (approximately 1 log10 reduction). Light 
irradiation did not alter the effect of MTZ on F. nucleatum biofilms. Regardless of the 
presence of light, the highest concentrations of antibiotic significantly reduced the log of 
CFU/mL, corresponding to 2.22 and 2.14 log10 reductions for the L
- 
MTZ 100x and L
+ 
MTZ 100x groups, respectively, compared to that for the control groups (P
-
L
-
 group) 
(Fig. 3A).  
For P. gingivalis biofilms, no difference in CFU/mL reduction was observed 
between aPDT with 100 mg/L PDZ and MTZ 100x without light (L
- 
MTZ 100x) 
compared to the control (L
-
) (2.59 log10 and 2.53 log10, respectively). A significant 
antimicrobial effect was achieved only when MTZ 100x was associated with red LED 
light (3.12 log10) and compared with the positive control (L
-
) (Fig. 3B).  
 
3.4 Effect of PDZ-mediated aPDT in association with MTZ on biofilms 
Since a substantial reduction in biofilm viability was observed with the highest 
concentration of aPDT and with MTZ, the potential effect of their association was also 
investigated. 
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For F. nucleatum biofilms, aPDT 75 mg/L PDZ plus MTZ 100x MIC (aPDT 75 
mg/L MTZ 100x) and aPDT 100 mg/L PDZ plus MTZ at concentrations of 50x MIC and 
100x MIC (aPDT 100 mg/L MTZ 50x and aPDT 100 mg/L MTZ 100x) significantly 
reduced the viability by 2.99, 2.9 and 3.94 log10, respectively. Compared with the control, 
P
-
L
-
, the combination of MTZ 100x MIC with aPDT 100 mg/L (aPDT 100 mg/L–MTZ 
100x) yielded pronounced antimicrobial activity by decreasing CFU by more than 3 log10 
CFU (Fig. 4A).  
For P. gingivalis biofilms, aPDT promoted a significant reduction in cell viability 
when combined with MTZ 100x, independent of the PDZ concentration. However, an 
extensive 5 log10 reduction was obtained with aPDT 100 mg/L PDZ in association with 
MTZ 100x MIC (aPDT 100 mg/L–MTZ 100x). In fact, light irradiation alone affected 
cell viability in P. gingivalis biofilms, as demonstrated by lower CFU/mL after light 
exposure in the (L
+
) groups compared with that in the L
-
 groups (Fig. 4B).  
 
3.5  Three-dimensional visualization of L+, PDZ, MTZ, PDZ-mediated aPDT in 
association with or without MTZ on biofilms 
The bacterial microcolony distribution and biofilm thickness was evaluated via confocal 
visualization to confirm the CFU/mL results obtained for L
+
, aPDT 100 mg/L PDZ, MTZ 
100x MIC, L
+
 MTZ 100x MIC, and aPDT 100 mg/L PDZ plus MTZ 100x MIC. 
Interestingly, compared with the positive control (L
-
), light alone did not affect F. 
nucleatum viability but interfered with biofilm thickness and cell distribution (Fig. 5A-B). 
Similar effects were also observed for aPDT. Specifically, aPDT contributed to F. 
nucleatum biofilm disturbances (Fig. 5C) since bacterial microcolonies from F. 
nucleatum biofilms were generally less abundant than those from F. nucleatum biofilms 
without light (Fig. 5A). Alternatively, MTZ alone did not seem to affect the F. nucleatum 
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biofilm structure because there was only a slight difference in overall green fluorescence 
intensity caused by application of MTZ to F. nucleatum biofilms (Fig. 5D) compared to 
that caused application of the control (Fig. 5A). The potential effect of MTZ was also 
investigated in combination with light or aPDT (Fig. 5E-F). Consistent with the observed 
difference in the number of F. nucleatum viable cells, fluorescent live/dead staining 
revealed a bactericidal effect when MTZ was applied in combination with L
+
 or aPDT 
(Fig. 5E-F). Light irradiation appeared to have a significant impact on the action of MTZ 
by disturbing bacterial cells on F. nucleatum biofilms (Fig. 5E-F). 
For P. gingivalis, a slight antibacterial effect was observed after biofilm exposure 
to light (L
+
) alone, with a marked reduction in biofilm thickness compared with that after 
exposure to the control (Fig. 6A-B). In the other evaluated groups, very few cells were 
nonviable (red color; Fig. 6C-E). In contrast to the controls, MTZ, aPDT and L
+ 
MTZ did 
not show markedly distinct effects on the spatial structure of P. gingivalis biofilms. The 
biofilms treated with aPDT in combination with MTZ (Fig. 6F) exhibited a vast number 
of dead bacterial cells without a significant detectable change in the biofilm thickness.  
 
4. Discussion 
aPDT has previously been demonstrated to kill planktonic periodontal pathogens [41, 50-
52]. However, the susceptibility of microorganisms to aPDT is considerably reduced 
when they are organized into biofilms. To gain new insight into the effect of PDZ-
mediated aPDT on anaerobic bacteria, we investigated the impact of different PDZ 
concentrations with or without light on F. nucleatum and P. gingivalis biofilms. Although 
PDZ-mediated aPDT promoted a significant viability reduction in both bacteria after 
therapeutic application, a potentiated antimicrobial effect was achieved only in 
combination with local MTZ antibiotic administration. 
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Bacteria organized in biofilms are highly resistant to conventional antimicrobial 
treatments [53]. Strong evidence indicates that F. nucleatum and P. gingivalis are two 
anaerobic species involved in the initiation and progression of periodontal and peri-
implant diseases [54]. The possibility of tooth and implant loss because of disease 
progression has encouraged the search for new strategies to disrupt pathogenic biofilms 
and disease progression with treatment. Considering the successful preliminary data 
obtained from PDZ-mediated aPDT by our research group [40, 43, 55], we moved 
forward and evaluated the effect of aPDT treatment against F. nucleatum and P. 
gingivalis biofilms. For F. nucleatum, the CFU/mL reduction was directly related to the 
association between the highest PDZ concentrations and light. Our data revealed that 75 
mg/L and 100 mg/L PDZ-mediated aPDT promoted 0.97 and 1.12 log10 reductions in 
CFU/mL, respectively. In contrast to our outcomes, a previous study demonstrated a 
significant effect against F. nucleatum ATCC 25586, with more than a 3 log10 reduction 
when aPDT with visible light (vis) and water infiltrated infrared A (wIRA) were 
combined with Ce6 [50]. The strong antimicrobial effect of aPDT against F. nucleatum 
cultures was also found in another recent study where 99.7% of the bacterial population 
died. However, these promising data cannot be compared with our data since the 
experiments were carried out in planktonic cultures [56]. Remarkably, the authors 
indicated a slight reduction in F. nucleatum cells even after light irradiation alone [56], 
which is consistent with our fluorescence information. However, in both reported studies 
[50, 56], the treatment was performed on planktonic bacterial species; this approach was 
inconsistent with our experimental approach in which we developed biofilms that 
presented a complex tridimensional architecture. Thus, the difference in microbial culture 
type can explain why the effect of aPDT was lower in our studies than in previous studies 
[50, 56].  
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For P. gingivalis, the effectiveness of aPDT was achieved only when PDZ was 
applied at the highest concentration (100 mg/L), resulting in a 2.66 log10 bacterial 
reduction. Despite the efficacy of aPDT against biofilm viability, an antimicrobial effect 
was not observed to ensure antibacterial properties since we obtained less than a 3 log10 
CFU reduction [57]. In contrast, an antimicrobial effect of aPDT using vis+wIRA 
combined with Ce6 was recently reported against different periodontal pathogens in a 
pool of subgingival oral biofilms with disruption of their tridimensional structures before 
the application of aPDT [50]. This disruption in the architecture of a biofilm can 
potentiate the effects of antimicrobial strategies. Here, biofilms with intact architecture 
were subjected to distinct antimicrobial approaches. Thus, the substantial differences in 
bacterial CFU reduction between this study and the previous study [38[50] can be 
explained by the different methodologies applied. In the previous study [50], subgingival 
oral biofilms were developed on in situ devices, but the biofilm samples were pooled, 
centrifuged and resuspended in saline solution [38]. Therefore, in that study, the treatment 
was applied to planktonic bacteria cells arising from biofilms; in contrast, in our study, 
aPDT was directly applied to a complex, organized pathogenic structure. 
In the absence of PDZ, exposure to light irradiation affected the viability of P. 
gingivalis cells [58]. The endogenous porphyrin production in the cell wall of P. 
gingivalis can explain this finding as porphyrin acts as a natural PS [59-62]. The 
susceptibility of some oral black-pigmented bacterial species to light irradiation in the 
absence of PS has been previously demonstrated in laboratory research and in vivo 
experiments [63]. Porphyrin is chemically excited by light of specific wavelengths [64] 
and promotes the generation of reactive oxygen species (ROS) capable of reacting and 
affecting biological systems [65]. Thus, P. gingivalis viability in culture medium is easily 
reduced by over 90% by exposure to 70 mW/cm² with a broadband light ranging from 
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380-520 nm, which includes blue light [63]. Using a similar power density of 71.7 
mW/cm², our results indicated a 1.33 log10 CFU/mL reduction in P. gingivalis after 28 
minutes of red light exposure at 660 nm. The notable difference in overall bacterial 
viability observed in our study may be explained by the, organized biofilm that we 
developed since the biofilm extracellular matrix can directly interfere with light diffusion 
[66, 67]. Surprisingly, the live/dead viability assay confirmed a slight effect of light on P. 
gingivalis biofilms, with red fluorescence emitted by dye-labeled dead cells and a marked 
reduction in biofilm thickness. Another interesting result was demonstrated by confocal 
imaging of F. nucleatum biofilms. Although CFU/mL counts were similar to those of F. 
nucleatum viable cells after L
+
 and aPDT compared with those after the control (L
-
), 
fluorescence analyses revealed a disturbed biofilm with sparse green areas and reduced 
pixel intensity in L
+
 and aPDT samples, respectively. The presence of red LED light (L
+
) 
seems to interfere with biofilm stability.  
Although PDZ-mediated aPDT significantly reduced the number of cultivable 
bacteria within biofilms, the effect of this therapy remains far below the microbial 
reduction rates required to be considered as an effective antimicrobial approach against F. 
nucleatum and P. gingivalis biofilms. To date, a major limitation of aPDT involves the 
poor uptake of PS. The idea of combining aPDT and local antibiotic delivery was 
undertaken in an attempt to widen the possibility of therapy application against 
pathogenic biofilms [68-70]. It is important to empathize that the dramatically question 
involving antibiotic is due to their indiscriminate systemic administration. Although, 
antibiotic resistance represents one of the biggest threats to global health and economic 
burden [71], systemic antibiotic prescription to fight periodontal and peri-implant disease 
still is strongly recommended [72]. From an overall healthcare perspective, microbial 
resistance and the development of superinfection as potential risks caused by antibiotic 
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therapy tackling the threatening possibility of bone resorption and subsequent tooth 
and/or dental implant loss [73]. Because antibiotics still are essential to treat infectious 
diseases, the local antibiotic administration has emerged as a possible coadjutant in 
reducing microbial resistance [74] and controlling inflammation in diseased periodontal 
sites [75-79]. Based on this principle, we first investigated the effect of different MTZ 
concentrations on the anaerobic biofilms of two bacterial strains. In agreement with the 
literature [80], we found that low concentrations of MTZ, specifically, 0.125 μg/mL and 1 
μg/mL, are sufficient to inhibit P. gingivalis and F. nucleatum growth in planktonic cells, 
respectively. MTZ possesses the ability of covalently binding to DNA, inhibiting 
bacterial nucleic acid synthesis and killing the cell. However, a different process is 
expected when MTZ is applied to biofilms [81]. The findings arising from controlled 
experiments have reported that biofilms are up to 1000 times more resistant to 
antimicrobial treatments than planktonic cells [82-84]. In our study, MTZ MIC, MTZ 50x 
and MTZ 100x showed no antimicrobial activity against either F. nucleatum or P. 
gingivalis biofilms.  
Our outcomes demonstrated that although aPDT did not display antimicrobial 
activity of 3 log (previously defined by [57]), the treatment with this approach 
significantly reduced the number of pathogenic bacteria inside the biofilm structure. 
Similar results were also observed to MTZ -treated groups, regardless antibiotic 
concentration. However, either aPDT neither MTZ was capable of destroying the 
organized structure and conferring the desired antimicrobial effect. Thus, to explore the 
potential upshot of the treatment we combined an antimicrobial agent that has excellent 
activity against strict anaerobic bacteria[85] after bacteria cells from biofilm being 
disturbed by aPDT. Based on the experimental outcomes from this study, MTZ seems to 
make biofilm cells more sensitive to PDZ penetration [69, 70], and antimicrobial activity 
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was strongly influenced by this association. One hundred mg/L PDZ-mediated aPDT 
associated with 100x MIC MTZ resulted in a significant 3.94 log10 CFU/mL reduction in 
bacterial load for F. nucleatum biofilms. Comparable antimicrobial activity was 
demonstrated for P. gingivalis grown as a biofilm since PDZ-mediated aPDT combined 
with 100x MIC MTZ promoted more than a 3 log10 reduction in CFU, regardless of the 
PDZ concentration. The remarkable effect of a 5 log10 P. gingivalis CFU reduction was 
achieved with 100 mg/L of PDZ-mediated aPDT combined with 100x MIC MTZ. 
Underlining the influence of light on porphyrins from the P. gingivalis cell wall, the 
higher efficacy of 100x MIC MTZ in the biofilm was obtained only after light exposure, 
leading to a 3.07 log10 CFU/mL reduction in bacterial viability. However, the desired 
antimicrobial properties were achieved only when MTZ was applied as an adjunctive 
therapy to inactivate F. nucleatum and P. gingivalis bacteria. The significant bactericidal 
activity against both single pathogenic biofilms was confirmed by live/dead viability 
assays via confocal microscopy.  
Indeed, aPDT remains under development. Although, PDZ-mediated aPDT has 
already demonstrated effectiveness against Candida albicans, for the management of 
denture stomatitis [86], the questions raised by our outcomes highlight the limitation of 
PDZ-mediated aPDT alone against anaerobic biofilms and the contribution of antibiotics 
to its success as an antimicrobial approach. From a clinical perspective, PDZ gel can be 
easily applied on the sick site for 20 minutes, followed by a light irradiation period of 4 
minutes (50 J/cm2) [86]. Further, the subsequent local delivery of antibiotics in the 
infected sites has already been descripted by the scientific community and can be carried 
out by using different approaches: fibers, films, microparticles and gels [87-90]. 
However, although we used a robust anaerobic biofilm model with human saliva to 
simulate an oral environment [47], polystyrene substrates are not natural surfaces on 
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which periodontal biofilm formation occurs. Therefore, the results obtained do not reflect 
the clinical setting. Furthermore, as our study was the first to investigate the use of PDZ-
mediated aPDT against anaerobic biofilms, we opted to grow bacteria in single-species 
cultures to reduce the number of variables and gain a better understanding of the benefits 
of aPDT against resistant infections. Additional in vitro experiments involving 
multispecies biofilm and tooth/implant substrates followed by in vivo research are 
necessary to determine the aPDT-antibiotic combination approach as a valuable prospect 
for future clinical implementation.  
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Figure Legends 
Fig. 1. A schematic illustration of the experimental setup performed to conduct this 
investigation. L
+
: under light irradiation; L
-
: without light irradiation; PDZ: 
photodithazine; 50 mg/L, 75 mg/L and 100 mg/L: photodithazine’s concentrations, aPDT: 
antimicrobial photodynamic therapy, MTZ: metronidazole, MIC, 50x and 100x: 
metronidazole’s concentrations. 
Fig. 2. (A) Effect of light and different concentrations of PDZ and aPDT on F. nucleatum 
biofilms. One-way analysis of variance (ANOVA) was employed with Tukey's post hoc 
test. (B) Effect of light and different concentration of PDZ and aPDT on P. gingivalis 
biofilms. The Kruskal-Wallis test was employed, followed by Dunn’s multiple 
comparison test. Bacterial counts after each treatment are expressed in logarithm of 
colony-forming units (CFU) per milliliter. Statistically significant differences are 
indicated as: 
*, +, **, #
 p<0.0001. Data represent the median ± SD of three biological 
replicates from three independent experiments by using GraphPad Prism version 5.0c.  
Fig. 3. Effect of MTZ in the presence and absence of light irradiation compared to that of 
aPDT on (A) F. nucleatum and (B) P. gingivalis biofilms. One-way analysis of variance 
(ANOVA) was employed with Tukey's post hoc test. Bacterial counts after each 
treatment are expressed in logarithm of colony-forming units (CFU) per milliliter. 
Statistically significant differences are indicated as: 
*, +, **, ***, #
 p<0.0001. Data represent 
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the mean ± SD of three biological replicates from three independent experiments by using 
GraphPad Prism version 5.0c.    
Fig. 4. Effect of aPDT in combination with MTZ at different concentrations on (A) F. 
nucleatum and (B) P. gingivalis biofilms. Gray lines: bacterial growth controls; Blue 
and Red lines: experimental groups disclosing antimicrobial effect. One-way analysis of 
variance (ANOVA) was employed with Tukey's post hoc test. Bacterial counts after each 
treatment are expressed in logarithm of colony-forming units (CFU) per milliliter. 
Statistically significant differences are indicated as: 
*, +, **, #
 p<0.0001. Data represent the 
mean ± SD of three biological replicates from three independent experiments, by using 
GraphPad Prism version 5.0c. 
Fig. 5. Representative images generated by confocal laser-scanning microscopy (z-axis 
stack) illustrating the effect of (B) L
+
, (C) aPDT 100 mg/L PDZ, (D) MTZ 100x MIC, 
(E) L
+
 MTZ 100x MIC,
 
and (F) aPDT 100 mg/L PDZ plus MTZ 100x MIC on F. 
nucleatum biofilms. The panels demonstrate the live and dead bacterial populations as 
well as microcolony distribution and biofilm thickness compared to those of the untreated 
F. nucleatum biofilm control group (A). The multiple Z sections in panels A to F were 
generated by sectioning at 50 μm.  
Fig. 6. Representative images generated by confocal laser-scanning microscopy (z-axis 
stack) images illustrating the effect of (B) L
+
, (C) aPDT 100 mg/L PDZ, (D) MTZ 100x 
MIC, (E) L
+
 MTZ 100x MIC,
 
and (F) aPDT 100 mg/L PDZ plus MTZ 100x MIC on P. 
gingivalis biofilms. The panels demonstrate the live and dead bacterial populations as 
well as microcolony distribution and biofilm thickness compared to those of the untreated 
P. gingivalis biofilm control group (A). The multiple Z sections in panels A to F were 
generated by sectioning at 50 μm. 
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Highlights  
 F. nucleatum and P. gingivalis are involved in the progression of oral diseases  
 PDZ-mediated aPDT reduces the number of bacteria within mature biofilms 
 MTZ seems to make biofilm cells more sensitive to PDZ penetration  
 Desired antimicrobial properties are achieved when MTZ is combined with PDZ-
mediated aPDT 
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